148 related articles for article (PubMed ID: 8093625)
1. Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting.
Bernstein JJ; Anagnostopoulos AV; Hattwick EA; Laws ER
J Neurosurg; 1993 Feb; 78(2):240-51. PubMed ID: 8093625
[TBL] [Abstract][Full Text] [Related]
2. Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro.
Bernstein JJ; Goldberg WJ; Laws ER
J Neurooncol; 1994; 18(2):151-61. PubMed ID: 7964977
[TBL] [Abstract][Full Text] [Related]
3. Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research.
Bernstein JJ; Goldberg WJ; Laws ER
J Neurosci Res; 1989 Feb; 22(2):134-43. PubMed ID: 2651679
[TBL] [Abstract][Full Text] [Related]
4. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
5. Migration of human malignant astrocytoma cells in the mammalian brain: Scherer revisited.
Laws ER; Goldberg WJ; Bernstein JJ
Int J Dev Neurosci; 1993 Oct; 11(5):691-7. PubMed ID: 8116480
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of human malignant astrocytoma cells xenografted to rat brain: apolipoprotein E.
Bernstein JJ; Goldberg WJ; Laws ER
Neurosurgery; 1989 Apr; 24(4):541-6. PubMed ID: 2710299
[TBL] [Abstract][Full Text] [Related]
7. Guanidinobenzoatase and UPA in high-grade human astrocytomas and after xenografting cell suspensions into the rat cerebral cortex: proteases for metastasis and disease progression.
Bernstein LJ; Tonn JC; Goldbrunner RH; Vince GH; Wagner S; Goldberg WJ
Anticancer Res; 1998; 18(4A):2583-90. PubMed ID: 9703913
[TBL] [Abstract][Full Text] [Related]
8. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
Kristt DA; Yarden Y
Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
10. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
Kristt DA; Reedy E; Yarden Y
Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
12. Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
Kharbanda K; Sarkar C; Dinda AK; Karak AK; Mathur M; Roy S
Acta Oncol; 1993; 32(3):301-6. PubMed ID: 8391834
[TBL] [Abstract][Full Text] [Related]
13. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal.
Martin S; Toquet C; Oliver L; Cartron PF; Perrin P; Meflah K; Cuillère P; Vallette FM
J Neurooncol; 2001 Apr; 52(2):129-39. PubMed ID: 11508812
[TBL] [Abstract][Full Text] [Related]
16. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
Yu D; Shi D; Scanlon M; Hung MC
Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
[TBL] [Abstract][Full Text] [Related]
17. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
18. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
[TBL] [Abstract][Full Text] [Related]
19. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
